Is it appropriate to repeat a dose of fosfomycin (fosfomycin trometamol) every 48 hours for an uncomplicated lower urinary tract infection?

Fosfomycin Every 48 Hours for UTI is NOT Recommended

For uncomplicated lower urinary tract infections (acute cystitis) in women, fosfomycin trometamol should be given as a single 3-gram dose only, not repeated every 48 hours. 1, 2

Why Single-Dose Only?

The FDA-approved dosing and all major international guidelines consistently specify fosfomycin as a single-dose therapy for uncomplicated cystitis 1, 3, 1, 4, 5, 2. The FDA label explicitly warns: "Do not use more than one single dose of fosfomycin tromethamine to treat a single episode of acute cystitis. Repeated daily doses of fosfomycin tromethamine did not improve the clinical success or microbiological eradication rates compared to single-dose therapy, but did increase the incidence of adverse events." 2

This is critical—repeating doses doesn't improve outcomes but does increase side effects.

When Multiple Doses Are Appropriate

The only scenario where multi-dose fosfomycin regimens are supported is for complicated lower UTIs (cLUTI), not uncomplicated cystitis:

• 3 grams every 48-72 hours for 3 total doses can be considered for cLUTI in patients who have failed other therapies, have multidrug-resistant pathogens, or cannot tolerate first-line agents 6
• This is "off-label" use and applies to complicated infections with risk factors (anatomic/functional abnormalities, comorbidities, instrumentation) 6

Standard Treatment for Uncomplicated Cystitis

For uncomplicated cystitis in women, the 2024 EAU guidelines recommend 1:

First-line options:

• Fosfomycin trometamol 3g single dose (1 day)
• Nitrofurantoin 100mg twice daily for 5 days
• Pivmecillinam 400mg three times daily for 3-5 days

Alternatives:

• Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days (if local E. coli resistance <20%)
• Cephalosporins (e.g., cefadroxil 500mg twice daily for 3 days)

Efficacy Considerations

While fosfomycin has excellent antimicrobial coverage and minimal collateral damage (resistance development, microbiome disruption), it shows slightly lower efficacy compared to other first-line agents 3:

• Clinical cure rates: 83-91% for fosfomycin vs. 88-95% for nitrofurantoin or trimethoprim-sulfamethoxazole 3, 5
• Microbiological cure: 78-80% for fosfomycin vs. 86-92% for nitrofurantoin 3

This inferior efficacy is acceptable for a single-dose regimen due to convenience and compliance benefits, but does not justify repeat dosing in uncomplicated cases.

Common Pitfall to Avoid

Do not confuse uncomplicated cystitis with complicated UTI or treatment failure. If symptoms persist or recur within 2 weeks after fosfomycin treatment:

1. Obtain urine culture and susceptibility testing 1
2. Assume the organism is not susceptible to fosfomycin
3. Retreat with a different agent for 7 days (not more fosfomycin) 1

Bottom Line

For uncomplicated cystitis: fosfomycin 3g × 1 dose only. For complicated lower UTI with specific indications: consider 3g every 48-72 hours × 3 doses. Never repeat fosfomycin every 48 hours for simple uncomplicated cystitis—it increases adverse events without improving outcomes.